WO2002083876A3 - Secretory molecules - Google Patents

Secretory molecules Download PDF

Info

Publication number
WO2002083876A3
WO2002083876A3 PCT/US2002/009921 US0209921W WO02083876A3 WO 2002083876 A3 WO2002083876 A3 WO 2002083876A3 US 0209921 W US0209921 W US 0209921W WO 02083876 A3 WO02083876 A3 WO 02083876A3
Authority
WO
WIPO (PCT)
Prior art keywords
sptm
provides
diagnostic assays
purified
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/009921
Other languages
French (fr)
Other versions
WO2002083876A2 (en
Inventor
Abel Daffo
Anissa L Jones
Alanna-Phung B Tran
Christopher R Dahl
Darryl Gietzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to AU2002311791A priority Critical patent/AU2002311791A1/en
Priority to CA002447212A priority patent/CA2447212A1/en
Priority to EP02739118A priority patent/EP1409504A2/en
Publication of WO2002083876A2 publication Critical patent/WO2002083876A2/en
Anticipated expiration legal-status Critical
Publication of WO2002083876A3 publication Critical patent/WO2002083876A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides purified secretory polynucleotides (sptm). Also encompassed are the polypeptides (SPTM) encoded by sptm. The invention also provides for the use of sptm, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing sptm for the expression of SPTM. The invention additionally provides for the use of isolated and purified SPTMto induce antibodies and to screen libraries of compounds and the use of anti-SPTM antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.
PCT/US2002/009921 2001-03-29 2002-03-27 Secretory molecules Ceased WO2002083876A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002311791A AU2002311791A1 (en) 2001-03-29 2002-03-27 Secretory molecules
CA002447212A CA2447212A1 (en) 2001-03-29 2002-03-27 Secretory molecules
EP02739118A EP1409504A2 (en) 2001-03-29 2002-03-27 Secretory molecules

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US28006801P 2001-03-29 2001-03-29
US28006701P 2001-03-29 2001-03-29
US60/280,068 2001-03-29
US60/280,067 2001-03-29
US29128001P 2001-05-16 2001-05-16
US60/291,280 2001-05-16
US29184901P 2001-05-17 2001-05-17
US29182901P 2001-05-17 2001-05-17
US60/291,849 2001-05-17
US60/291,829 2001-05-17
US29942801P 2001-06-19 2001-06-19
US60/299,428 2001-06-19
US30000101P 2001-06-20 2001-06-20
US29977601P 2001-06-20 2001-06-20
US60/299,776 2001-06-20
US60/300,001 2001-06-20

Publications (2)

Publication Number Publication Date
WO2002083876A2 WO2002083876A2 (en) 2002-10-24
WO2002083876A3 true WO2002083876A3 (en) 2004-02-19

Family

ID=27575326

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/009921 Ceased WO2002083876A2 (en) 2001-03-29 2002-03-27 Secretory molecules

Country Status (4)

Country Link
EP (1) EP1409504A2 (en)
AU (1) AU2002311791A1 (en)
CA (1) CA2447212A1 (en)
WO (1) WO2002083876A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7227008B2 (en) 1999-04-12 2007-06-05 Agensys, Inc. 13-transmembrane protein expressed in prostate cancer
US7309585B2 (en) 2001-03-05 2007-12-18 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
WO2003059948A1 (en) * 2002-01-15 2003-07-24 Medigene Ag Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
US7485709B2 (en) * 2002-05-31 2009-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Identification of a novel BHD gene
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2005003336A2 (en) 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
JP5572938B2 (en) * 2007-10-25 2014-08-20 東レ株式会社 Immune inducer
ES2748390T3 (en) * 2007-10-25 2020-03-16 Toray Industries Cancer screening method
AU2008314925B2 (en) 2007-10-25 2013-11-07 Toray Industries, Inc. Immune response inducer
AR091069A1 (en) 2012-05-18 2014-12-30 Amgen Inc PROTEINS OF UNION TO ANTIGEN DIRECTED AGAINST THE ST2 RECEIVER

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 10 August 2000 (2000-08-10), "National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index", XP002964530, accession no. NCBI Database accession no. (BE552030) *
DATABASE GENBANK [online] 7 July 2000 (2000-07-07), WATERSON R.H.: "The sequence of homo sapiens clone", XP002964529, accession no. NCBI Database accession no. (AC023786) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7227008B2 (en) 1999-04-12 2007-06-05 Agensys, Inc. 13-transmembrane protein expressed in prostate cancer
US7306796B2 (en) 1999-04-12 2007-12-11 Agensys, Inc. 13-transmembrane protein expressed in prostate cancer
US7309585B2 (en) 2001-03-05 2007-12-18 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers

Also Published As

Publication number Publication date
CA2447212A1 (en) 2002-10-24
EP1409504A2 (en) 2004-04-21
WO2002083876A2 (en) 2002-10-24
AU2002311791A1 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
WO2002097031A3 (en) Molecules for diagnostics and therapeutics
WO2004023973A3 (en) Molecules for diagnostics and therapeutics
WO2002083876A3 (en) Secretory molecules
WO2004092209A3 (en) S. pneumoniae antigens
WO2000073509A3 (en) Molecules for diagnostics and therapeutics
WO2004078907A3 (en) Streptococcus pyogenes antigens
WO2001004264A3 (en) Atherosclerosis-associated genes
EP0897004A3 (en) Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS)
WO2005103073A3 (en) Td antigens
WO2003020894A3 (en) Insulin related transcription factor and uses thereof
WO2002099080A3 (en) Methods for low background cloning of dna using long oligonucleotides
WO2002046228A3 (en) Receptor for b. anthracis toxin
WO2001068859A3 (en) Il-17 receptor like molecules and uses thereof
WO2002020756A3 (en) Secretory molecules
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
WO2002040715A8 (en) Molecules for disease detection and treatment
WO2003062376A3 (en) Molecules for diagnostics and therapeutics
WO2003062385A3 (en) Secretory molecules
WO2004094467A3 (en) H. pylori antigens
WO2001062918A3 (en) Secretory polypeptides and corresponding polynucleotides
WO2001062927A3 (en) Polypeptides and corresponding polynucleotides for diagnostics and therapeutics
WO2001062922A3 (en) Polypeptides and corresponding molecules for disease detection and treatment
WO2002055738A3 (en) Molecules for disease detection and treatment
WO2002057304A3 (en) Secretory molecules
WO2002020754A3 (en) Molecules for diagnostics and therapeutics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002739118

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2447212

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002739118

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002739118

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP